Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00
Provider: Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Select Medical Holdings Corp Reaffirms FY 2013 Guidance


Thursday, 8 Aug 2013 05:00pm EDT 

Select Medical Holdings Corp announced that it reaffirming its prior business outlook provided in its May 2, 2013 earnings press release for net operating revenues, Adjusted EBITDA and adjusted income per common share and continues to expect consolidated net operating revenues to be in the range of $2.925 billion to $3.025 billion, Adjusted EBITDA to be in the range of $375.0 million to $390.0 million and adjusted income per common share, which excludes the losses on early retirement of debt and their related tax effects in the first and second quarters, for the fiscal 2013 to be in the range of $0.87 to $0.94. Select Medical expects fully diluted income per common share for the fiscal 2013 to be in the range of $0.78 to $0.85. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $2.966 billion, EBITDA of $378 million and EPS of $0.91 for fiscal 2013. 

Company Quote

12.74
-0.08 -0.62%
24 Oct 2014